Doximity (DOCS)
(Delayed Data from NYSE)
$27.50 USD
+0.41 (1.51%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $27.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DOCS 27.50 +0.41(1.51%)
Will DOCS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOCS
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?
Doximity (DOCS) Upgraded to Buy: Here's What You Should Know
Company News for May 20, 2024
Other News for DOCS
Dr Martens backs outlook as trades in line early in new financial year
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days